By KAISER PERMANENTE A research study released on April 22, 2022, in The Lancet Respiratory Medicine shows that a booster dose of the Pfizer COVID-19 vaccine provides strong protection, roughly 80% to 90%, in the first few months against hospital...
Previous COVID-19 Infection – But NOT Vaccination – Improves Performance of Antibodies
By EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASE New research to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon, April 23-26) shows that, although over time the number...
Vitamin D Deficiency Linked With Increased COVID-19 Severity and Mortality
By BAR-ILAN UNIVERSITY Joint Bar-Ilan University, Galilee Medical Center study affirms that sufficient vitamin D levels may positively influence the outcome of infection. Vitamin D is most often recognized for its role in bone health, but low levels of the supplement...
Researchers Discover Two Paths Toward “Super Immunity” to COVID-19
By OREGON HEALTH & SCIENCE UNIVERSITY OHSU laboratory research compares routes to immunity involving vaccination. New laboratory research from Oregon Health & Science University reveals more than one path toward robust immunity from COVID-19. A new study...
COVID-19 Omicron Variant Resistant to Monoclonal Antibodies – But Neutralized by Vaccine Booster
By INSTITUT PASTEUR The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the dominant variant within a few weeks or months. Initial epidemiological studies show that the...
UCLA Breakthrough Points Way to Longer-Lasting COVID Vaccine
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses. The findings...
Combination of Natural Infection and Vaccination Provides Maximum Protection Against COVID Variants
By UCLA Health Sciences A combination of vaccination and naturally acquired infection appears to boost the production of maximally potent antibodies against the COVID-19 virus, new UCLA research finds. The findings, published on December 7, 20221, in...
Worried About the COVID Delta Variant? Experts Explain Risk of Breakthrough Infections to the Vaccinated
As breakthrough infections rise from the highly contagious Delta variant of the coronavirus, the precise risk to the fully vaccinated may be confusing. Northwestern Medicine experts explain why the number of breakthrough infections from the Delta variant are going up,...
Promising At-Home Treatment for COVID-19 Discovered: FDA Approved Drug for Leprosy
https://www.covidstrategies.org/promising-at-home-treatment-for-covid-19-discovered-fda-approved-drug-for-leprosy-2/https://scitechdaily.com/promising-at-home-Integrative Therapies,Treatment-for-covid-19-discovered-fda-approved-drug-for-leprosy/ Originally published by: Scitechdaily Author: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Date: 3/16/2021 Categories: Integrative...